A minimal level of MHC class II expression is sufficient to abrogate autoreactivity

被引:12
作者
de Bont, ESJM
Reilly, CR
Lo, D
Glimcher, LH
Laufer, TM
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
关键词
dendritic cell; lysozyme promoter; macrophage; MHC class II; negative selection;
D O I
10.1093/intimm/11.8.1295
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The establishment of CD4(+) T cell tolerance requires that self-reactive thymocytes are negatively selected during thymic development. A threshold of antigen concentration appears to exist for both MHC class I- and class II-mediated negative selection, below which clonal deletion of a self-reactive transgenic TCR does not occur. Similarly, both the specificity and thymic concentration of MHC molecules affect the efficiency with which autoreactive thymocytes are deleted. However, this threshold for MHC class II concentration has not been well established. Here, we show that this threshold must be extraordinarily low. We have used the human lysozyme promoter to re-express an A(beta)(b) cDNA on macrophages and other phagocytic myelomonocytic cells of class Il-deficient A(beta)(b) -/- mice. Surface expression of I-Ab could be detected on mature peritoneal macrophages and, minimally, on thymic dendritic cells; however, this level of expression was not sufficient for antigen-specific T cell activation. Nevertheless, when backcrossed onto an autoreactive K14 background, this minimal level of class II was sufficient to induce negative selection of a polyclonal self-reactive population. We conclude that provision of extremely low levels of class II to thymic dendritic cells confers on them the ability to mediate clonal deletion of autoreactive T cells.
引用
收藏
页码:1295 / 1305
页数:11
相关论文
共 44 条
  • [1] EVIDENCE FOR A DIFFERENTIAL AVIDITY MODEL OF T-CELL SELECTION IN THE THYMUS
    ASHTONRICKARDT, PG
    BANDEIRA, A
    DELANEY, JR
    VANKAER, L
    PIRCHER, HP
    ZINKERNAGEL, RM
    TONEGAWA, S
    [J]. CELL, 1994, 76 (04) : 651 - 663
  • [2] POSITIVE SELECTION OF THE T-CELL REPERTOIRE - WHERE AND WHEN DOES IT OCCUR
    BENOIST, C
    MATHIS, D
    [J]. CELL, 1989, 58 (06) : 1027 - 1033
  • [3] PHENOTYPIC DIFFERENCES BETWEEN ALPHA-BETA-T-CELL VERSUS BETA-T-CELL RECEPTOR TRANSGENIC MICE UNDERGOING NEGATIVE SELECTION
    BERG, LJ
    FAZEKAS DE ST GROTH, B
    PULLEN, AM
    DAVIS, MM
    [J]. NATURE, 1989, 340 (6234) : 559 - 562
  • [4] ANTIGEN MHC-SPECIFIC T-CELLS ARE PREFERENTIALLY EXPORTED FROM THE THYMUS IN THE PRESENCE OF THEIR MHC LIGAND
    BERG, LJ
    PULLEN, AM
    FAZEKAS DE ST GROTH, B
    MATHIS, D
    BENOIST, C
    DAVIS, MM
    [J]. CELL, 1989, 58 (06) : 1035 - 1046
  • [5] POSITIVE SELECTION OF CD4+T CELLS MEDIATED BY MHC CLASS-II-BEARING STROMAL CELL IN THE THYMIC CORTEX
    BILL, J
    PALMER, E
    [J]. NATURE, 1989, 341 (6243) : 649 - 651
  • [6] Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo
    Brocker, T
    Riedinger, M
    Karjalainen, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) : 541 - 550
  • [7] BURKLY LC, 1993, J IMMUNOL, V151, P3954
  • [8] The human lysozyme promoter directs reporter gene expression to activated myelomonocytic cells in transgenic mice
    Clarke, S
    Greaves, DR
    Chung, LP
    Tree, P
    Gordon, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) : 1434 - 1438
  • [9] TISSUE-SPECIFIC TARGETING OF CYTOKINE UNRESPONSIVENESS IN TRANSGENIC MICE
    DIGHE, AS
    CAMPBELL, D
    HSIEH, CS
    CLARKE, S
    GREAVES, DR
    GORDON, S
    MURPHY, KM
    SCHREIBER, RD
    [J]. IMMUNITY, 1995, 3 (05) : 657 - 666
  • [10] INSIDE THE THYMUS, MLS ANTIGEN IS EXCLUSIVELY PRESENTED BY LYMPHOCYTES-B
    FARO, J
    MARCOS, MAR
    ANDREU, JL
    MARTINEZ, C
    COUTINHO, A
    [J]. RESEARCH IN IMMUNOLOGY, 1990, 141 (08): : 723 - 737